Laura Braconi

发表

New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators

C. Supuran, Niccolò Chiaramonte, Alessio Gabellini, 2022, Molecules.

6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers

N. Colabufo, C. Riganti, Niccolò Chiaramonte, 2020, Journal of enzyme inhibition and medicinal chemistry.

The piperazine scaffold for novel drug discovery efforts: the evidence to date

Alessio Gabellini, Laura Braconi, S. Dei, 2022, Expert opinion on drug discovery.

1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in Escherichia coli.

L. Gardini, M. Capitanio, F. Pavone, 2020, Future microbiology.

Simultaneous Degradation Study of Isomers in Human Plasma by HPLC-MS/MS and Application of LEDA Algorithm for Their Characterization

G. Bartolucci, Laura Braconi, S. Dei, 2022, International journal of molecular sciences.

Application of LEDA algorithm for the recognition of P-glycoprotein and Carbonic Anhydrase hybrid inhibitors and evaluation of their plasma stability by HPLC-MS/MS analysis.

C. Supuran, G. Bartolucci, Laura Braconi, 2022, Journal of pharmaceutical and biomedical analysis.

2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and Antiglaucoma activity

C. Supuran, Niccolò Chiaramonte, A. Angeli, 2021, European Journal of Medicinal Chemistry.

Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors.

C. Supuran, M. Ferraroni, Niccolò Chiaramonte, 2019, Bioorganic chemistry.

Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine1

C. Supuran, Niccolò Chiaramonte, A. Angeli, 2020, Journal of enzyme inhibition and medicinal chemistry.

Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells †

C. Supuran, A. Lapucci, G. Bartolucci, 2020, Molecules.

New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells

C. Supuran, C. Riganti, G. Bartolucci, 2022, Journal of medicinal chemistry.

Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators

Laura Braconi, S. Dei, E. Teodori, 2019, Cancer drug resistance.

Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers.

N. Colabufo, E. Gazzano, C. Riganti, 2019, European journal of medicinal chemistry.

Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.

N. Colabufo, Niccolò Chiaramonte, G. Bartolucci, 2019, European journal of medicinal chemistry.

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators

H. Arias, Alessio Gabellini, Laura Braconi, 2023, Molecules.

Overcoming Multidrug Resistance (MDR): Design, Biological Evaluation and Molecular Modelling Studies of 2,4‐Substituted Quinazoline Derivatives

N. Colabufo, C. Riganti, G. Bartolucci, 2022, ChemMedChem.

Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers.

N. Colabufo, C. Riganti, G. Bartolucci, 2023, European journal of medicinal chemistry.

Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm

G. Bartolucci, Laura Braconi, S. Dei, 2023, International journal of molecular sciences.

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023

G. Marotta, Alessio Gabellini, Laura Braconi, 2023, Molecules.